Primary cutaneous cryptococcosis: A distinct clinical entity

被引:157
作者
Neuville, S
Dromer, F
Morin, O
Dupont, B
Ronin, O
Lortholary, O
机构
[1] Inst Pasteur, Unite Mycol Mol, Ctr Natl Reference Mycoses & Antifong, F-75724 Paris 15, France
[2] Hop Necker Enfants Malad, Serv Malad Infect & Trop, Paris, France
[3] Hop Hotel Dieu, Lab Parasitol Mycol, Nantes, France
[4] Hop Avicenne, Serv Malad Infect & Trop, F-93009 Bobigny, France
关键词
D O I
10.1086/345956
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cryptococcus neoformans is an encapsulated yeast responsible for disseminated meningitis in immunocompromised hosts. Controversies persist on the existence of primary cutaneous cryptococcosis (PCC) versus cutaneous cryptococcosis being only secondary to hematogenous dissemination. Thus, we reviewed cryptococcosis cases associated with skin lesions reported in the French National Registry. Patients with PCC (n = 28) differed significantly from those with secondary cutaneous cryptococcosis (n = 80) or other forms of the disease (n = 1866) by living area (mostly rural), age (older), ratio of men to women (similar to1: 1), and the lack of underlying disease. Evidence of PCC included the absence of dissemination and, predominantly, a solitary skin lesion on unclothed areas presenting as a whitlow or phlegmon, a history of skin injury, participation in outdoor activities, or exposure to bird droppings, and isolation of C. neoformans serotype D. Therefore, PCC is a distinct epidemiological and clinical entity with a favorable prognosis even for immunocompromised hosts.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 104 条
[11]   Primary cutaneous cryptococcosis following trauma of the right forearm [J].
Bohne, T ;
Sander, A ;
PfisterWartha, A ;
Schopf, E .
MYCOSES, 1996, 39 (11-12) :457-459
[12]  
Butler W P, 1985, NITA, V8, P295
[13]   MANAGEMENT OF INJURIES CAUSED BY CRYPTOCOCCUS NEOFORMANS-CONTAMINATED NEEDLES [J].
CASADEVALL, A ;
MUKHERJEE, J ;
YUAN, RR ;
PERFECT, J .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (05) :951-953
[14]   Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia [J].
Chrétien, F ;
Lortholary, O ;
Kansau, I ;
Neuville, S ;
Gray, F ;
Dromer, F .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (04) :522-530
[15]   CUTANEOUS CRYPTOCOCCOSIS [J].
CHU, AC ;
HAY, RJ ;
MACDONALD, DM .
BRITISH JOURNAL OF DERMATOLOGY, 1980, 103 (01) :95-&
[16]   HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE SKIN - A CRUCIAL INTERFACE [J].
COCKERELL, CJ .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (07) :1295-1303
[17]   CRYPTOCOCCOSIS - CASE WITH UNUSUAL SKIN LESIONS AND FAVORABLE RESPONSE TO AMPHOTERICIN B THERAPY [J].
CROUNSE, RG ;
LERNER, AB .
ARCHIVES OF DERMATOLOGY, 1958, 77 (02) :210-215
[18]  
CUSINI M, 1991, ARCH DERMATOL, V127, P1848, DOI 10.1001/archderm.127.12.1848
[19]   PROGNOSTIC FACTORS IN CRYPTOCOCCAL MENINGITIS - STUDY IN 111 CASES [J].
DIAMOND, RD ;
BENNETT, JE .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :176-181
[20]   DISSEMINATED CRYPTOCOCCOSIS IN MAN - DECREASED LYMPHOCYTE TRANSFORMATION IN RESPONSE TO CRYPTOCOCCUS-NEOFORMANS [J].
DIAMOND, RD ;
BENNETT, JE .
JOURNAL OF INFECTIOUS DISEASES, 1973, 127 (06) :694-697